Click here to get full coverage on Is It Too Late To Consider Axogen (AXGN) After Its 75% One Year Surge? - simplywall.st

Is It Too Late To Consider Axogen (AXGN) After Its 75% One Year Surge?  simplywall.st

Is It Too Late To Consider Axogen (AXGN) After Its 75% One Year Surge? - simplywall.st

Click here to get full coverage on AXGN: Canaccord Genuity Maintains 'Buy' Rating with $40 Target | - GuruFocus

AXGN: Canaccord Genuity Maintains 'Buy' Rating with $40 Target |  GuruFocus

AXGN: Canaccord Genuity Maintains 'Buy' Rating with $40 Target | - GuruFocus

Click here to get full coverage on AxoGen's (AXGN) "Buy" Rating Reaffirmed at Canaccord Genuity Group - MarketBeat

AxoGen's (AXGN) "Buy" Rating Reaffirmed at Canaccord Genuity Group  MarketBeat

AxoGen's (AXGN) "Buy" Rating Reaffirmed at Canaccord Genuity Group - MarketBeat

Click here to get full coverage on Vanguard realigns reporting; Axogen (NASDAQ: AXGN) shows 0 shares owned - Stock Titan

Vanguard realigns reporting; Axogen (NASDAQ: AXGN) shows 0 shares owned  Stock Titan

Vanguard realigns reporting; Axogen (NASDAQ: AXGN) shows 0 shares owned - Stock Titan

Click here to get full coverage on CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛

CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $40  富途牛牛

CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛

Click here to get full coverage on (AXGN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

(AXGN) Price Dynamics and Execution-Aware Positioning  Stock Traders Daily

(AXGN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Click here to get full coverage on Is Axogen (AXGN) Fairly Priced After Strong 72.7% One Year Share Gain - finance.yahoo.com

Is Axogen (AXGN) Fairly Priced After Strong 72.7% One Year Share Gain  finance.yahoo.com

Is Axogen (AXGN) Fairly Priced After Strong 72.7% One Year Share Gain - finance.yahoo.com

Click here to get full coverage on Axogen Q4: EPS Miss Amid Biologics Transition (NASDAQ:AXGN) - seekingalpha.com

Axogen Q4: EPS Miss Amid Biologics Transition (NASDAQ:AXGN)  seekingalpha.com

Axogen Q4: EPS Miss Amid Biologics Transition (NASDAQ:AXGN) - seekingalpha.com

Click here to get full coverage on AxoGen, Inc. (NASDAQ:AXGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

AxoGen, Inc. (NASDAQ:AXGN) Receives Consensus Rating of "Moderate Buy" from Analysts  MarketBeat

AxoGen, Inc. (NASDAQ:AXGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Click here to get full coverage on A Look At Axogen (AXGN) Valuation After Its Upsized US$124 Million Equity Offering - finance.yahoo.com

A Look At Axogen (AXGN) Valuation After Its Upsized US$124 Million Equity Offering  finance.yahoo.com

A Look At Axogen (AXGN) Valuation After Its Upsized US$124 Million Equity Offering - finance.yahoo.com

Click here to get full coverage on Axogen (AXGN) innovation chief reports stock awards and tax-share withholding - Stock Titan

Axogen (AXGN) innovation chief reports stock awards and tax-share withholding  Stock Titan

Axogen (AXGN) innovation chief reports stock awards and tax-share withholding - Stock Titan

Click here to get full coverage on Assessing Axogen (AXGN) Valuation After Growth Outlook And FDA Approval Fuel Strong One Year Share Price Gain - simplywall.st

Assessing Axogen (AXGN) Valuation After Growth Outlook And FDA Approval Fuel Strong One Year Share Price Gain  simplywall.st

Assessing Axogen (AXGN) Valuation After Growth Outlook And FDA Approval Fuel Strong One Year Share Price Gain - simplywall.st

Click here to get full coverage on Axogen (NASDAQ:AXGN) shareholder returns have been strong, earning 161% in 3 years - finance.yahoo.com

Axogen (NASDAQ:AXGN) shareholder returns have been strong, earning 161% in 3 years  finance.yahoo.com

Axogen (NASDAQ:AXGN) shareholder returns have been strong, earning 161% in 3 years - finance.yahoo.com

Click here to get full coverage on Axogen (AXGN) officer nets shares after RSU vesting and sale - Stock Titan

Axogen (AXGN) officer nets shares after RSU vesting and sale  Stock Titan

Axogen (AXGN) officer nets shares after RSU vesting and sale - Stock Titan

Click here to get full coverage on Is It Too Late To Consider Axogen (AXGN) After Its Strong Three Year Run - simplywall.st

Is It Too Late To Consider Axogen (AXGN) After Its Strong Three Year Run  simplywall.st

Is It Too Late To Consider Axogen (AXGN) After Its Strong Three Year Run - simplywall.st

Click here to get full coverage on Breakeven Is Near for Axogen, Inc. (NASDAQ:AXGN) - finance.yahoo.com

Breakeven Is Near for Axogen, Inc. (NASDAQ:AXGN)  finance.yahoo.com

Breakeven Is Near for Axogen, Inc. (NASDAQ:AXGN) - finance.yahoo.com

Click here to get full coverage on Axogen (AXGN) CFO nets shares from 9,000 RSU vesting as company withholds stock for taxes - Stock Titan

Axogen (AXGN) CFO nets shares from 9,000 RSU vesting as company withholds stock for taxes  Stock Titan

Axogen (AXGN) CFO nets shares from 9,000 RSU vesting as company withholds stock for taxes - Stock Titan

Click here to get full coverage on Axogen (AXGN) Benefited from Multiple Tailwinds - finance.yahoo.com

Axogen (AXGN) Benefited from Multiple Tailwinds  finance.yahoo.com

Axogen (AXGN) Benefited from Multiple Tailwinds - finance.yahoo.com

Click here to get full coverage on AxoGen (AXGN) Q4 Earnings Miss Estimates - finance.yahoo.com

AxoGen (AXGN) Q4 Earnings Miss Estimates  finance.yahoo.com

AxoGen (AXGN) Q4 Earnings Miss Estimates - finance.yahoo.com

Click here to get full coverage on This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth - The Globe and Mail

This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth  The Globe and Mail

This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth - The Globe and Mail

Click here to get full coverage on AxoGen (AXGN) Q3 Earnings and Revenues Top Estimates - finance.yahoo.com

AxoGen (AXGN) Q3 Earnings and Revenues Top Estimates  finance.yahoo.com

AxoGen (AXGN) Q3 Earnings and Revenues Top Estimates - finance.yahoo.com

Click here to get full coverage on AXOGEN ($AXGN) Releases Q4 2025 Earnings - Quiver Quantitative

AXOGEN ($AXGN) Releases Q4 2025 Earnings  Quiver Quantitative

AXOGEN ($AXGN) Releases Q4 2025 Earnings - Quiver Quantitative

Click here to get full coverage on AXGN SEC Filings - Axogen Inc 10-K, 10-Q, 8-K Forms - Stock Titan

AXGN SEC Filings - Axogen Inc 10-K, 10-Q, 8-K Forms  Stock Titan

AXGN SEC Filings - Axogen Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on AxoGen, Inc. $AXGN is First Light Asset Management LLC's Largest Position - MarketBeat

AxoGen, Inc. $AXGN is First Light Asset Management LLC's Largest Position  MarketBeat

AxoGen, Inc. $AXGN is First Light Asset Management LLC's Largest Position - MarketBeat

Click here to get full coverage on With 88% ownership of the shares, Axogen, Inc. (NASDAQ:AXGN) is heavily dominated by institutional owners - finance.yahoo.com

With 88% ownership of the shares, Axogen, Inc. (NASDAQ:AXGN) is heavily dominated by institutional owners  finance.yahoo.com

With 88% ownership of the shares, Axogen, Inc. (NASDAQ:AXGN) is heavily dominated by institutional owners - finance.yahoo.com

Click here to get full coverage on Royce & Associates LP Purchases New Shares in AxoGen, Inc. $AXGN - MarketBeat

Royce & Associates LP Purchases New Shares in AxoGen, Inc. $AXGN  MarketBeat

Royce & Associates LP Purchases New Shares in AxoGen, Inc. $AXGN - MarketBeat

Click here to get full coverage on Axogen (AXGN): Revenue Forecast to Grow 13.8% Annually Heading Into Earnings Season - finance.yahoo.com

Axogen (AXGN): Revenue Forecast to Grow 13.8% Annually Heading Into Earnings Season  finance.yahoo.com

Axogen (AXGN): Revenue Forecast to Grow 13.8% Annually Heading Into Earnings Season - finance.yahoo.com

Click here to get full coverage on Surgical nerve repair company Axogen prices $124M stock sale to pay off term loan - Stock Titan

Surgical nerve repair company Axogen prices $124M stock sale to pay off term loan  Stock Titan

Surgical nerve repair company Axogen prices $124M stock sale to pay off term loan - Stock Titan

Click here to get full coverage on Why Is AXGN Stock Rising Today? - Stocktwits

Why Is AXGN Stock Rising Today?  Stocktwits

Why Is AXGN Stock Rising Today? - Stocktwits

Click here to get full coverage on A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations - finance.yahoo.com

A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations  finance.yahoo.com

A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations - finance.yahoo.com

Click here to get full coverage on Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know - The Motley Fool

Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know  The Motley Fool

Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know - The Motley Fool

Click here to get full coverage on AXGN: Broad BLA label, exclusivity, and expanded coverage drive growth in nerve care markets - TradingView

AXGN: Broad BLA label, exclusivity, and expanded coverage drive growth in nerve care markets  TradingView

AXGN: Broad BLA label, exclusivity, and expanded coverage drive growth in nerve care markets - TradingView

Click here to get full coverage on Should Axogen’s 2026 Growth Guidance Amid Wider Losses Require Action From Axogen (AXGN) Investors? - simplywall.st

Should Axogen’s 2026 Growth Guidance Amid Wider Losses Require Action From Axogen (AXGN) Investors?  simplywall.st

Should Axogen’s 2026 Growth Guidance Amid Wider Losses Require Action From Axogen (AXGN) Investors? - simplywall.st

Click here to get full coverage on Axogen plans $85M stock sale to repay loan and fund operations - Stock Titan

Axogen plans $85M stock sale to repay loan and fund operations  Stock Titan

Axogen plans $85M stock sale to repay loan and fund operations - Stock Titan

Click here to get full coverage on Should You Think About Buying Axogen, Inc. (NASDAQ:AXGN) Now? - finance.yahoo.com

Should You Think About Buying Axogen, Inc. (NASDAQ:AXGN) Now?  finance.yahoo.com

Should You Think About Buying Axogen, Inc. (NASDAQ:AXGN) Now? - finance.yahoo.com

Click here to get full coverage on $AXGN stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

$AXGN stock is up 8% today. Here's what we see in our data.  Quiver Quantitative

$AXGN stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on When Will Axogen, Inc. (NASDAQ:AXGN) Breakeven? - finance.yahoo.com

When Will Axogen, Inc. (NASDAQ:AXGN) Breakeven?  finance.yahoo.com

When Will Axogen, Inc. (NASDAQ:AXGN) Breakeven? - finance.yahoo.com

Click here to get full coverage on Erick Wayne Devinney Sells 5,221 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat

Erick Wayne Devinney Sells 5,221 Shares of AxoGen (NASDAQ:AXGN) Stock  MarketBeat

Erick Wayne Devinney Sells 5,221 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat

Click here to get full coverage on Axogen (NASDAQ: AXGN) secures FDA BLA approval for Avance biologic, U.S. launch expected in Q2 2026 - Stock Titan

Axogen (NASDAQ: AXGN) secures FDA BLA approval for Avance biologic, U.S. launch expected in Q2 2026  Stock Titan

Axogen (NASDAQ: AXGN) secures FDA BLA approval for Avance biologic, U.S. launch expected in Q2 2026 - Stock Titan

Click here to get full coverage on Do Options Traders Know Something About Axogen Stock We Don't? - TradingView

Do Options Traders Know Something About Axogen Stock We Don't?  TradingView

Do Options Traders Know Something About Axogen Stock We Don't? - TradingView

Click here to get full coverage on (AXGN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

(AXGN) as a Liquidity Pulse for Institutional Tactics  Stock Traders Daily

(AXGN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Click here to get full coverage on With 88% ownership in Axogen, Inc. (NASDAQ:AXGN), institutional investors have a lot riding on the business - simplywall.st

With 88% ownership in Axogen, Inc. (NASDAQ:AXGN), institutional investors have a lot riding on the business  simplywall.st

With 88% ownership in Axogen, Inc. (NASDAQ:AXGN), institutional investors have a lot riding on the business - simplywall.st

Click here to get full coverage on FDA-approved nerve graft helps Axogen grow sales 20% in 2025 - Stock Titan

FDA-approved nerve graft helps Axogen grow sales 20% in 2025  Stock Titan

FDA-approved nerve graft helps Axogen grow sales 20% in 2025 - Stock Titan

Click here to get full coverage on Axogen (AXGN) CMO granted 23,000 RSUs and adjusts share holdings - Stock Titan

Axogen (AXGN) CMO granted 23,000 RSUs and adjusts share holdings  Stock Titan

Axogen (AXGN) CMO granted 23,000 RSUs and adjusts share holdings - Stock Titan

Click here to get full coverage on AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm  Business Wire

AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Click here to get full coverage on A Look at Axogen (AXGN) Valuation Following FDA Avance Delay and Securities Law Probe - finance.yahoo.com

A Look at Axogen (AXGN) Valuation Following FDA Avance Delay and Securities Law Probe  finance.yahoo.com

A Look at Axogen (AXGN) Valuation Following FDA Avance Delay and Securities Law Probe - finance.yahoo.com

Click here to get full coverage on (AXGN) Risk Channels and Responsive Allocation - Stock Traders Daily

(AXGN) Risk Channels and Responsive Allocation  Stock Traders Daily

(AXGN) Risk Channels and Responsive Allocation - Stock Traders Daily

Click here to get full coverage on Company insider, form4 insider - GuruFocus

Company insider, form4 insider  GuruFocus

Company insider, form4 insider - GuruFocus

Click here to get full coverage on Insider Sale: Director at $AXGN Sells 20,436 Shares - Quiver Quantitative

Insider Sale: Director at $AXGN Sells 20,436 Shares  Quiver Quantitative

Insider Sale: Director at $AXGN Sells 20,436 Shares - Quiver Quantitative

Click here to get full coverage on Axogen, Inc. Plans $85 Million Public Offering of Common Stock - Quiver Quantitative

Axogen, Inc. Plans $85 Million Public Offering of Common Stock  Quiver Quantitative

Axogen, Inc. Plans $85 Million Public Offering of Common Stock - Quiver Quantitative

Click here to get full coverage on Insider Sale: Director at $AXGN Sells 14,571 Shares - Quiver Quantitative

Insider Sale: Director at $AXGN Sells 14,571 Shares  Quiver Quantitative

Insider Sale: Director at $AXGN Sells 14,571 Shares - Quiver Quantitative

Click here to get full coverage on Axogen, Inc. (NASDAQ:AXGN) Looks Just Right With A 30% Price Jump - simplywall.st

Axogen, Inc. (NASDAQ:AXGN) Looks Just Right With A 30% Price Jump  simplywall.st

Axogen, Inc. (NASDAQ:AXGN) Looks Just Right With A 30% Price Jump - simplywall.st

Click here to get full coverage on Equity awards and tax share withholding for Axogen (NASDAQ: AXGN) CFO - Stock Titan

Equity awards and tax share withholding for Axogen (NASDAQ: AXGN) CFO  Stock Titan

Equity awards and tax share withholding for Axogen (NASDAQ: AXGN) CFO - Stock Titan

Click here to get full coverage on Why Axogen (AXGN) Is Down 10.1% After Avance FDA Win and 2026 Guidance Shift - Sahm

Why Axogen (AXGN) Is Down 10.1% After Avance FDA Win and 2026 Guidance Shift  Sahm

Why Axogen (AXGN) Is Down 10.1% After Avance FDA Win and 2026 Guidance Shift - Sahm

Click here to get full coverage on (AXGN) Movement as an Input in Quant Signal Sets - Stock Traders Daily

(AXGN) Movement as an Input in Quant Signal Sets  Stock Traders Daily

(AXGN) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Click here to get full coverage on Returns Are Gaining Momentum At Axogen (NASDAQ:AXGN) - simplywall.st

Returns Are Gaining Momentum At Axogen (NASDAQ:AXGN)  simplywall.st

Returns Are Gaining Momentum At Axogen (NASDAQ:AXGN) - simplywall.st

Click here to get full coverage on Axogen, Inc. Reports Strong Preliminary Fourth Quarter and Full-Year 2025 Financial Results | AXGN Stock News - Quiver Quantitative

Axogen, Inc. Reports Strong Preliminary Fourth Quarter and Full-Year 2025 Financial Results | AXGN Stock News  Quiver Quantitative

Axogen, Inc. Reports Strong Preliminary Fourth Quarter and Full-Year 2025 Financial Results | AXGN Stock News - Quiver Quantitative

Click here to get full coverage on Trade Alert: President Of Axogen Michael Dale Has Sold Stock - simplywall.st

Trade Alert: President Of Axogen Michael Dale Has Sold Stock  simplywall.st

Trade Alert: President Of Axogen Michael Dale Has Sold Stock - simplywall.st

Click here to get full coverage on Avance Nerve Graft FDA Verdict Approaches, Why Investors Are Watching Axogen (NASDAQ:AXGN) - seekingalpha.com

Avance Nerve Graft FDA Verdict Approaches, Why Investors Are Watching Axogen (NASDAQ:AXGN)  seekingalpha.com

Avance Nerve Graft FDA Verdict Approaches, Why Investors Are Watching Axogen (NASDAQ:AXGN) - seekingalpha.com

Click here to get full coverage on Axogen (AXGN) Q4 2025 Earnings Call Transcript - AOL.com

Axogen (AXGN) Q4 2025 Earnings Call Transcript  AOL.com

Axogen (AXGN) Q4 2025 Earnings Call Transcript - AOL.com

Click here to get full coverage on Understanding Momentum Shifts in (AXGN) - Stock Traders Daily

Understanding Momentum Shifts in (AXGN)  Stock Traders Daily

Understanding Momentum Shifts in (AXGN) - Stock Traders Daily

Click here to get full coverage on Axogen (AXGN) Achieves Financial Milestones and Strategic Goals in 2025 - GuruFocus

Axogen (AXGN) Achieves Financial Milestones and Strategic Goals in 2025  GuruFocus

Axogen (AXGN) Achieves Financial Milestones and Strategic Goals in 2025 - GuruFocus

Click here to get full coverage on AxoGen (AXGN) Receives a Buy from H.C. Wainwright - The Globe and Mail

AxoGen (AXGN) Receives a Buy from H.C. Wainwright  The Globe and Mail

AxoGen (AXGN) Receives a Buy from H.C. Wainwright - The Globe and Mail

Click here to get full coverage on Axogen, Inc. (NASDAQ:AXGN) Could Be Less Than A Year Away From Profitability - webull.com

Axogen, Inc. (NASDAQ:AXGN) Could Be Less Than A Year Away From Profitability  webull.com

Axogen, Inc. (NASDAQ:AXGN) Could Be Less Than A Year Away From Profitability - webull.com

Click here to get full coverage on Do Options Traders Know Something About Axogen Stock We Don't? - finance.yahoo.com

Do Options Traders Know Something About Axogen Stock We Don't?  finance.yahoo.com

Do Options Traders Know Something About Axogen Stock We Don't? - finance.yahoo.com

Click here to get full coverage on AxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

AxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Moderate Buy" by Analysts  MarketBeat

AxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Click here to get full coverage on Axogen, Inc. Receives FDA Approval for AVANCE® Biologics License Application to Treat Peripheral Nerve Discontinuities - Quiver Quantitative

Axogen, Inc. Receives FDA Approval for AVANCE® Biologics License Application to Treat Peripheral Nerve Discontinuities  Quiver Quantitative

AXGN

Price Chart

Key Statistics

Technicals

About AXGN

Latest News

Is It Too Late To Consider Axogen (AXGN) After Its 75% One Year Surge? - simplywall.st

AXGN: Canaccord Genuity Maintains 'Buy' Rating with $40 Target | - GuruFocus

AxoGen's (AXGN) "Buy" Rating Reaffirmed at Canaccord Genuity Group - MarketBeat

Advanced Charts

Top Gainers

Top Losers